DiaMedica Therapeutics Inc. (DMAC) FCF Margin (2018)
DiaMedica Therapeutics (DMAC) has 1 years of FCF Margin data on record, last reported at 371.8% in Q3 2018.
- For Q3 2018, FCF Margin changed N/A year-over-year to 371.8%; the TTM value through Jun 2019 reached 1950.2%, changed N/A, while the annual FY2024 figure was 65002.94%, 2023342.0% down from the prior year.
- FCF Margin reached 371.8% in Q3 2018 per DMAC's latest filing.
- Across five years, FCF Margin topped out at 371.8% in Q3 2018 and bottomed at 371.8% in Q3 2018.